Tokyo, December 6, 2019 --- Hitachi, Ltd. (TSE:6501, “Hitachi”) today announced that it has entered into an agreement to provide Centro Nazionale di Adroterapia Oncologica (CNAO) with its proton therapy system.
In comprehensive public tender process, Hitachi has been selected to provide proton therapy system with latest technologies including advanced scanning technology to irradiate even tumors with complex shapes with high precision.
The New Energy and Industrial Technology Development Organization ("NEDO") announced today that the Smart Grid Demonstration Project, aimed at the expansion of renewable energy in Poland, entered power grid protection system (“SPS: Special Protection Scheme”) operational demonstration phase. The solution implementation, was executed by Hitachi, Ltd. ("Hitachi"), Hitachi Chemical Co., Ltd. ("Hitachi Chemical") and Sumitomo Mitsui Banking Corporation ("SMBC") in cooperation with Polish partner companies, Polskie Sieci Elektroenergetyczne S.A. (“PSE”), ENERGA-OPERATOR S.A.
20th November 2019 - Barclays has today unveiled its enhanced finger vein scanner, which will help businesses access their banking facilities securely and simply in seconds.
ROCHESTER, Minn. And TOKYO, Japan November 19, 2019 --- Mayo Clinic and Hitachi, Ltd. (TSE:6501) have reached an agreement in principle to build a carbon ion treatment facility as part of Mayo Clinic's recently announced integrated oncology facility which will be constructed at Mayo Clinic's campus in Jacksonville, Florida.
While carbon ion therapy was discovered in the United States in the 1970s, there currently are no carbon ion therapy treatment centers in North America. The technology is only available at a handful of centers in Asia and Europe.
London, 18 November 2019 -- The University of Cambridge (“the University”) and Hitachi, Ltd. (TSE: 6501, "Hitachi"), today announced that they have signed a new agreement to continue and grow their long-standing relationship through the Hitachi Cambridge Laboratory (HCL), part of the European R&D Centre of Hitachi Europe Ltd., a wholly owned subsidiary of Hitachi.
Lyon, France, 6 November, 2019 --- Hitachi, Ltd. (TSE:6501, “Hitachi”) and Centre Léon Bérard (CLB), a leading French Comprehensive Cancer Center in Lyon-France, announced today that they have entered into an agreement to jointly promote research and development aimed at improving the efficiency of diagnosis and treatment of cancer and established a new research laboratory called Hitachi Lyon Lab on the CLB site, starting November 5th.
Tokyo, October 30, 2019 --- Hitachi, Ltd. (TSE:6501) today announced that the Board of Directors decided the interim dividend for the fiscal year ending March 31, 2020 as shown below in view of earnings performance and other factors.
Hitachi, Ltd. (TSE: 6501, “Hitachi”), Honda Motor Co., Ltd. (TSE: 7267, “Honda”), Hitachi Automotive Systems, Ltd. (“Hitachi Automotive Systems”), Keihin Corporation (TSE: 7251, “Keihin”), Showa Corporation (TSE: 7274, “Showa”), and Nissin Kogyo Co., Ltd. (TSE: 7230, “Nissin”) hereby announce that these six companies have each resolved in their board of directors meetings held today that, on the precondition that permits and licenses, etc.
Tokyo, October 30, 2019 --- Hitachi, Ltd. (TSE:6501) today announced its consolidated financial results for the second quarter of fiscal 2019, ended September 30, 2019
Tokyo, October 29, 2019 --- Hitachi, Ltd. (TSE:6501, “Hitachi”) today announced that Hitachi has provided its advanced proton therapy system to Sibley Memorial Hospital (Washington DC, US), a member of Johns Hopkins Medicine (Maryland, US), and it has started treatment on October 25, 2019. On October 28, an opening ceremony at Sibley Memorial Hospital was held.
Search
Europe